Becton Dickinson (LTS:0R19) Research & Development: $1,174 Mil (TTM As of Mar. 2026)


LTS:0R19 Becton Dickinson & Co LTS:0R19
76 GF Score
Price $145.59
GF Value $190.16
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Research & Development?

Becton Dickinson LTS:0R19 +2.75% 76 Research & Development is $1,174 Mil as of Mar. 2026. GuruFocus rates LTS:0R19 with a GF Score™ of 76/100 and a GF Value™ of $190.16 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Becton Dickinson's Research & Development for the three months ended in Mar. 2026 was $249 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $1,174 Mil.

Becton Dickinson  (LTS:0R19) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Becton Dickinson Research & Development Related Terms

Becton Dickinson Research & Development Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Research & Development Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,279.00 1,256.00 1,237.00 1,190.00 1,265.00

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 232.00 297.00 322.00 306.00 249.00
LTS:0R19
76GF Score
Becton Dickinson & Co LTS:0R19
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,174 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1,174 Mil mean?
Becton Dickinson (LTS:0R19) has a Research & Development of $1,174 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Research & Development too high?
Becton Dickinson's current Research & Development is $1,174 Mil. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Research & Development compare to MDLN and RMD?
Becton Dickinson's Research & Development of $1,174 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Research & Development is $1,174 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (LTS:0R19) is currently considered Modestly Undervalued. The stock's GF Value™ is $190.16, compared to a current price of $145.59 — trading 23.4% below its estimated fair value. The current Research & Development is $1,174 Mil. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Becton Dickinson (LTS:0R19), the current Research & Development is $1,174 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (LTS:0R19) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of $145.59 is trading 23.4% below its estimated GF Value™ of $190.16. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for LTS:0R19:

  • Research & Development: $1,174 Mil
  • GF Value™: $190.16 vs. price of $145.59 (23.4% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the LTS:0R19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score

Get the complete analysis for LTS:0R19

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$145.59
Price
$190.16
GF Value